Amarantus BioScience Holdings, Inc.
AMBS
$0.00
$0.000.00%
OTC PK
| 06/30/2019 | 03/31/2019 | 06/30/2018 | |||
|---|---|---|---|---|---|
| Net Income | -412.00K | -412.00K | -1.74M | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -- | -- | 3.77M | ||
| Change in Net Operating Assets | 1.04M | 1.04M | 438.50K | ||
| Cash from Operations | 630.90K | 630.90K | 2.47M | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -1.01M | -1.01M | -272.60K | ||
| Cash from Investing | -1.01M | -1.01M | -272.60K | ||
| Total Debt Issued | 1.03M | 1.03M | 7.79M | ||
| Total Debt Repaid | -14.30K | -14.30K | -3.84M | ||
| Issuance of Common Stock | 13.60K | 13.60K | 1.22M | ||
| Repurchase of Common Stock | -7.90K | -7.90K | -- | ||
| Issuance of Preferred Stock | -- | -- | 577.30K | ||
| Repurchase of Preferred Stock | -643.00K | -643.00K | -6.48M | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -1.48M | ||
| Cash from Financing | 381.90K | 381.90K | -2.22M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | ||
| Net Change in Cash | -300.00 | -300.00 | -25.60K | ||